DK2211851T3 - Laminin-1 til anvendelse til forbedring af muskelregenerering efter skade eller til forbedring af sårheling ved systemisk administration - Google Patents

Laminin-1 til anvendelse til forbedring af muskelregenerering efter skade eller til forbedring af sårheling ved systemisk administration

Info

Publication number
DK2211851T3
DK2211851T3 DK08836948.3T DK08836948T DK2211851T3 DK 2211851 T3 DK2211851 T3 DK 2211851T3 DK 08836948 T DK08836948 T DK 08836948T DK 2211851 T3 DK2211851 T3 DK 2211851T3
Authority
DK
Denmark
Prior art keywords
improving
laminin
injury
wound healing
systemic administration
Prior art date
Application number
DK08836948.3T
Other languages
English (en)
Inventor
Dean J Burkin
Jachinta E Rooney
Original Assignee
Univ Nevada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nevada filed Critical Univ Nevada
Application granted granted Critical
Publication of DK2211851T3 publication Critical patent/DK2211851T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK08836948.3T 2007-10-09 2008-10-01 Laminin-1 til anvendelse til forbedring af muskelregenerering efter skade eller til forbedring af sårheling ved systemisk administration DK2211851T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99832007P 2007-10-09 2007-10-09
PCT/US2008/078459 WO2009048778A2 (en) 2007-10-09 2008-10-01 Laminins, derivatives, and compositions including same and method for their therapeutic use

Publications (1)

Publication Number Publication Date
DK2211851T3 true DK2211851T3 (da) 2014-07-14

Family

ID=40523424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08836948.3T DK2211851T3 (da) 2007-10-09 2008-10-01 Laminin-1 til anvendelse til forbedring af muskelregenerering efter skade eller til forbedring af sårheling ved systemisk administration

Country Status (14)

Country Link
US (4) US8193145B2 (da)
EP (2) EP2803355A1 (da)
JP (2) JP5566294B2 (da)
CN (1) CN101873854B (da)
AU (1) AU2008311076B2 (da)
CA (1) CA2739719C (da)
CY (1) CY1115550T1 (da)
DK (1) DK2211851T3 (da)
ES (1) ES2483902T3 (da)
HR (1) HRP20140657T1 (da)
PL (1) PL2211851T3 (da)
PT (1) PT2211851E (da)
SI (1) SI2211851T1 (da)
WO (1) WO2009048778A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2211851T1 (sl) 2007-10-09 2014-11-28 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Laminin-1 za uporabo pri izboljĺ anju regeneracije miĺ ice po poĺ kodbi ali za izboljĺ anje celjenja ran ob sistemski administraciji
US9566310B2 (en) 2012-09-10 2017-02-14 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy
JP2016516051A (ja) * 2013-03-15 2016-06-02 ボード オブ リージェンツ オブ ザ ネヴァダ システム オブ ハイヤー エデュケーション オン ビハーフ オブ ザ ユニヴァーシティー オブ ネヴァダ リノ 筋ジストロフィーを治療する方法
JP6161953B2 (ja) * 2013-05-23 2017-07-12 日本メナード化粧品株式会社 育毛剤、筋肉活性化剤及びエネルギー産生促進剤
WO2016183277A1 (en) * 2015-05-12 2016-11-17 Northwestern University Materials for tissue regeneration
CN105820235A (zh) * 2016-04-20 2016-08-03 王丛飞 一种血浆层粘连蛋白提取方法
CN107537023A (zh) * 2016-06-27 2018-01-05 王丛飞 一种层粘连蛋白创面修护剂
WO2018022880A1 (en) * 2016-07-28 2018-02-01 Sanofi Compositions and methods for muscle progenitor cell-based therapies
CN107261116A (zh) * 2017-06-17 2017-10-20 河南艾尔恩生物技术有限公司 一种促进组织再生修复剂
CN111135111A (zh) * 2018-11-06 2020-05-12 王丛飞 一种层黏连蛋白皮肤修复剂及其制备方法
CN110075280A (zh) * 2019-04-30 2019-08-02 王丛飞 一种层粘连蛋白肽复合口服剂及其制备方法
CN110308283B (zh) * 2019-06-28 2021-09-10 迪瑞医疗科技股份有限公司 一种层粘连蛋白校准品及质控品

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
WO1991011462A2 (en) 1990-01-30 1991-08-08 La Jolla Cancer Research Foundation Merosin, nucleic acids encoding, fragments and uses thereof
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6933280B2 (en) 1996-10-08 2005-08-23 Gerardo Castillo Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
ES2297852T3 (es) 1996-10-08 2008-05-01 University Of Washington Aplicaciones terapeuticas de laminina y de fragmentos proteicos obtenidos a partir de laminina.
US6682911B1 (en) 1997-10-10 2004-01-27 The General Hospital Corporation Laminins and uses thereof
WO1999036105A2 (en) * 1998-01-16 1999-07-22 Mca Development B.V. USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
US6294356B1 (en) 1998-01-16 2001-09-25 Northwestern University Methods and materials for making and using laminin-5
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
WO2000055181A1 (en) 1999-03-15 2000-09-21 The General Hospital Corporation Methods of modulating cell attachment and migration
US6703363B1 (en) 1999-04-30 2004-03-09 Biostratum, Inc. Recombinant laminin 5
EP1177291A2 (en) 1999-04-30 2002-02-06 Biostratum, Inc. Laminin 8 and methods for its use
US6632790B1 (en) * 1999-04-30 2003-10-14 University Of Medicine And Dentistry Of New Jersey Laminin 2 and methods for its use
US20050069985A1 (en) 2001-02-20 2005-03-31 The Board Of Trustees Of The University Of Illinois Assay methods and amelioration of muscular dystrophy symptoms
US6858395B2 (en) 2001-02-20 2005-02-22 The Board Of Trustees Of The University Of Illinois Diagnostics assay methods and amelioration of muscular dystrophy symptoms
WO2003085092A2 (en) 2002-04-01 2003-10-16 Law Peter K Cellular transplantation for heart regeneration
US7078379B2 (en) * 2002-06-03 2006-07-18 Santhera Pharmaceuticals (Schweiz) Gmbh Treatment of congenital muscular dystrophies
ATE292021T1 (de) * 2003-01-10 2005-04-15 Ilford Imaging Ch Gmbh Aufzeichnungsmaterial für den tintenstrahldruck
EP1617854B1 (en) 2003-02-21 2014-08-06 The Uab Research Foundation Biologically active native biomatrix composition
US20050058687A1 (en) 2003-09-12 2005-03-17 Becton, Dickinson And Company Covalently attached collagen VI for cell attachment and proliferation
US7749754B2 (en) 2004-06-09 2010-07-06 The Board Of Trustees Of The Leland Stanford Junior University Isolation and characterization of muscle regenerating cells
US7563828B2 (en) * 2004-07-16 2009-07-21 Alcatel-Lucent Usa Inc. Solid state proton conductor system derived from hybrid composite inorganic-organic multicomponent material
US7531355B2 (en) 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
SI2211851T1 (sl) 2007-10-09 2014-11-28 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Laminin-1 za uporabo pri izboljĺ anju regeneracije miĺ ice po poĺ kodbi ali za izboljĺ anje celjenja ran ob sistemski administraciji

Also Published As

Publication number Publication date
EP2211851A2 (en) 2010-08-04
US8193145B2 (en) 2012-06-05
US20090092587A1 (en) 2009-04-09
US20140227231A1 (en) 2014-08-14
AU2008311076B2 (en) 2014-06-12
CN101873854B (zh) 2014-09-10
JP2014196326A (ja) 2014-10-16
CA2739719C (en) 2017-01-10
WO2009048778A2 (en) 2009-04-16
ES2483902T3 (es) 2014-08-08
CY1115550T1 (el) 2017-01-04
HRP20140657T1 (hr) 2014-11-07
EP2803355A1 (en) 2014-11-19
EP2211851A4 (en) 2012-01-04
WO2009048778A3 (en) 2009-07-09
JP5566294B2 (ja) 2014-08-06
PT2211851E (pt) 2014-07-28
JP2011500576A (ja) 2011-01-06
AU2008311076A1 (en) 2009-04-16
CA2739719A1 (en) 2009-04-16
EP2211851B1 (en) 2014-06-11
SI2211851T1 (sl) 2014-11-28
PL2211851T3 (pl) 2014-11-28
US20120207720A1 (en) 2012-08-16
CN101873854A (zh) 2010-10-27
US20150352183A1 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
DK2211851T3 (da) Laminin-1 til anvendelse til forbedring af muskelregenerering efter skade eller til forbedring af sårheling ved systemisk administration
LTC2340031I2 (lt) Gdf gaudyklės, skirtos naudoti anemijos gydymui
BR112012003445A2 (pt) aparelho dental sem o uso das maos para limpeza dos dentes
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0818056A2 (pt) Aparelho e métodos para hemodiálise
BRPI0916763A2 (pt) dialisador
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
BRPI0914274A2 (pt) plataforma
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
DE602008003400D1 (de) Wabenstruktur
DK2340100T3 (da) Filterenhed med filterbank
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
DE602009001201D1 (de) Wabenstruktur
SMT201500237B (it) Compsizione per l'uso in un trattamento contro l'infertilità
BRPI0916186A2 (pt) vacinas de idna e métodos para uso das mesma
NO20063936L (no) Anordning ved lopeskinne
DE602009000269D1 (de) Wabenstruktur
DE602009000270D1 (de) Wabenstruktur
DE502009000386D1 (de) Sicherungseinrichtung
FIU20090158U0 (fi) Invertterin suodatinrakenne
IT1391542B1 (it) Cassaforte
SE0950136L (sv) Ställningsplattform med utbytbart ställningsplan
ES1065731Y (es) Plataforma deslizante perfeccionada para la construccion
FR2932367B1 (fr) Sangle reglable en longeur
ES1068985Y (es) Mejoras en mordaza para la colocacion de guardacuerpos en las obras de la construccion